This publication was withdrawn on
This competition is no longer open. Search current funding opportunities.
Up to £4 million capital investment is available to enable research into antimicrobial resistance and advance the development of new products.
This competition opened on 14 September 2016 and is now closed for registrations.
Open to any UK organisation, Innovate UK are delivering a competition on behalf of the Department of Health to invest up to £4 million to support the UK’s capability to conduct research into antimicrobial resistance (AMR). The aim will be to develop new products and services that will reduce the impact of drug resistant pathogens, slow down the emergence of new ones, and produce new products and services including drugs, vaccines and diagnostics.
Focusing on antibacterial resistance, the competition aims to:
- strengthen research and innovation excellence across the UK
- maximise private sector engagement and leverage funding
- capitalise on existing UK expertise in AMR research and innovation
- support and use capability in different regions
Successful applicants must spend and claim their grant by 31 March 2017.
We expect funding requests to be between £200,000 and £2 million but larger and smaller grants will be considered (see funding section).
The competition project is open to any UK organisation working on its own or in a consortium.
You must register before noon on 27 October 2016.
You must apply before noon on 2 November 2016.
Watch the webinar of the briefing event in London on 19 September 2016
Not right for your innovation project? View other Innovate UK funding competitions.
Published: 14 September 2016
Updated: 27 October 2016
- Removed registration link
- Made it clear that funding requests can be larger or smaller than the stated amount.
- Added a link to the recorded webinar for the briefing event.
- Under funding, made clear that capital investment is also known as "investment aid for research infrastructure".
- First published.